Stockreport

Arcturus Therapeutics Holdings Inc (ARCT) Q3 2024 Earnings Call Highlights: Strategic Advances ... [Yahoo! Finance]

Arcturus Therapeutics Holdings Inc.  (ARCT) 
Last arcturus therapeutics holdings inc. earnings: 3/11 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.arcturusrx.com/investor-relations
PDF Research and Development Expenses: $39.1 million for Q3 2024, down from $51.1 million in Q3 2023. Net Loss: $6.9 million or $0.26 per diluted share for Q3 2024, compa [Read more]